Center
for Drug Evaluation &
Research (CDER) News |
Center
for Biologics Evaluation &
Research (CBER) |
Center
for Device &
Radiological
Health (CDRH) |
Federal Register -
Meetings, Notices, & Rule Changes |
|
September 12, 2008
September 11, 2008
September 9, 2008
-
Cyber Letters for Years:
2005,
2006,
2007 (updated)
-
Guidance for Industry: Concept
Papers
-
Animal Models Essential
Elements to Address Efficacy
Under the Animal Rule [PDF]
-
PDUFA Pilot Project:
Proprietary Name Review [PDF]
-
New
and Generic Drug Approvals
-
Monistat 3
(miconazole nitrate) Vaginal
Cream, Johnson and Johnson
Healthcare Products,
Manufacturing Change or
Addition
-
Photofrin
(porfimer sodium) Injection,
Axcan Pharma US, Inc.,
Efficacy Supplement with
Clinical Data to Support
September 8, 2008
CDER Drug Links
|
Approval Information: Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant (Gardasil) - Merck
Posted: 9/12/2008; Approval Date: 9/12/2008Approval Information: Immune Globulin Intravenous (Human) (Gamunex) - Talecris Biotherapeutics, Inc.
Posted: 9/12/2008; Approval Date: 9/12/2008
Substantially Equivalent 510(k) Device - Pool Results Manager Version 1.0C
Posted: 9/12/2008, Clearance Date: 9/3/2008
Important Notification: Red Cell Collection Kits - Haemonetics Corporation
Posted: 9/12/2008: Notification Date: 9/9/2008
Approval Information: Blood Grouping Reagent Anti-Fya (Monoclonal) (Seraclone) - Approval History and Related Documents
Posted: 9/12/2008
Approval Information: Blood Grouping Reagent Anti-S (Monoclonal) (Seraclone) - Approval History and Related Documents
Posted: 9/12/2008
Approval Information: Blood Grouping Reagent Anti-s (Monoclonal) (Seraclone) - Approval history and related documents
Posted: 9/12/2008
Influenza Virus Vaccine 2008/2009 Season Lot Release Status - Update
Posted: 9/10/2008
Vacancy Announcement - Supervisory Medical Officer, DVRPA/OVRR
Posted: 9/9/2008
Vacancy Announcement - Supervisory Interdisciplinary Scientist, DVRPA/OVRR
Posted: 9/9/2008
Concept Paper: Animal Models Essential Elements to Address Efficacy Under the Animal Rule (PDF)
Posted: 9/9/2008
Recall of Thymoglobulin [Anti-thymocyte Globulin (Rabbit)] - Genzyme Corporation
Posted: 9/9/2008, Recall Date: 8/22/2008
FEDERAL REGISTER: Amendments to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals, Final Rule
Posted: 9/8/2008
Guidance for Industry: General Principles for the Development of Vaccines to Protect Against Global Infectious Diseases
Posted: 9/8/2008
CBER Links
|
| September 12, 2008 |
 |
Federal Register: Medical Devices: Ophthalmic Devices; Laser-Assisted In Situ Keratomileusis (LASIK) Devices; Establishing a Docket   |
| |
| September 11, 2008 |
 |
Federal Register: Class II Special Controls Guidance Document: Absorbable Hemostatic Device; Draft Guidance for Industry and Food and Drug Administration Staff; Reopening of Comment Period   |
 |
Summary Information for: COBAS TaqMan HBV Test For Use With the High Pure System  |
 |
FDA Workshop: Best Practices For Pacemaker and ICD Lead Postmarket Surveillance, October 2-3, 2008 (Final Agenda Now Available)  |
 |
Federal Register: General and Plastic Surgery Devices: Reclassification of the Absorbable Hemostatic Device; Reopening of Comment Period   |
 |
Class I Medical Device Recall: Physio Control, Inc. LifePak CR Plus Automated External Defibrillators (AEDs)  |
 |
Federal Register: Public Advisory Panels or Committees: Request for Industry Organizations Interested in Participating in Selection Process for Nonvoting Industry Representatives   |
| |
| September 9, 2008 |
 |
Federal Register: Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 020   |
| |
| September 8, 2008 |
 |
Federal Register: FDA Clinical Trial Requirements Regulations, Compliance, and Good Clinical Practice Conference; Public Workshop   |
| |
|
|
|
|
|
|
Medical Device Links
|
|
This
Week
Rule Changes:
210/211 Drug GMPs |
|
Friday,
Sept. 12, 2008 |
|
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals:
Food Canning Establishment
Registration, Process
Filing, and Recordkeeping of
Acidified Foods, etc.,
53028 [E821353]
[TEXT] [PDF]
Medical Devices:
Ophthalmic Devices;
Laser-Assisted In Situ
Keratomileusis (LASIK)
Devices; Establishing a
Docket,
5302853029 [E821339]
[TEXT] [PDF]
Over-the-Counter Sunscreen
Drug Products for Human Use:
Ecamsule Eligibility for
Inclusion in Monograph;
Request for Safety and
Effectiveness Data
|
|
Thursday,
Sept. 11, 2008 |
PROPOSED RULES
General and Plastic Surgery
Devices:
Reclassification of the
Absorbable Hemostatic
Device; Reopening of Comment
Period,
5280452805 [E821200]
[TEXT] [PDF]
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals,
52861 [E821020]
[TEXT] [PDF]
Class II Special Controls
Guidance Document:
Absorbable
Hemostatic Device; Draft
Guidance for Industry and
Food and Drug Administration
Staff; Reopening of Comment
Period,
5286152862 [E821197]
[TEXT] [PDF]
Public Advisory Panels or
Committees:
Request for
Industry Organizations
Interested in Participating
in Selection Process for
Nonvoting Industry
Representatives,
5286252863 [E821016]
[TEXT] [PDF]
|
|
Wed.,
Sept. 10, 2008 |
|
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals,
5266352664 [E820933]
[TEXT] [PDF]
|
|
Tuesday,
Sept. 09, 2008 |
|
NOTICES
Determination That TEQUIN (Gatifloxacin)
Was Withdrawn From Sale for
Reasons of Safety or
Effectiveness,
5235752358 [E820938]
[TEXT] [PDF]
Food and Drug Administration
Modernization Act (1997):
Modifications to the List of
Recognized Standards,
Recognition List Number 020,
5235852385 [E820939]
[TEXT] [PDF]
Memorandum of Understanding
Between the Food and Drug
Administration and the
University of Pennsylvania,
5238552392 [E820932]
[TEXT] [PDF]
|
|
Monday,
Sept. 08, 2008 |
|
RULES
Amendments to Current Good
Manufacturing Practice
Regulations for Finished
Pharmaceuticals,
5191951933 [E820709]
[TEXT] [PDF]
Control of Communicable
Diseases:
Restrictions on African
Rodents, Pairie Dogs, and
Certain Other Animals,
5191251919 [E820779]
[TEXT] [PDF]
NOTICES
FDA Clinical Trial
Requirements Regulations,
Compliance, and Good
Clinical Practice
Conference; Public Workshop,
52052 [E820730]
[TEXT] [PDF]
|
|
|
|
.jpg)



EU - US - ICH GMP
Combination Product
handbook |
|
US GMP Training Booklet |
|
Std. GMPs
- Parts 11, 210, 211, 820 &
ICH Q7 |
|
Med. Device - 11, 50,
54, 56, 807, 812, 814, 820,
510k/PMA |
|
Clinical GCP - Parts 11,
50, 54, 56, 312, 314 & ICH
E2A & E6 |
|
Multi-US GMPs 11, 58,
210/211, 600, 601, 610
& 820 |
|
Parts 210/211 - Drug
GMPs |
|
>210/211
with Part 11 |
|
>210/211
with Part 820 |
|
>210/211
with Parts 820 & 11 |
|
>210/211
w/ Keyword Index |
Part 820
Quality Systems Regs
|
|
Part 58 - GLP Good
Lab. Practice |
Part 11
- Electronic Records w/
Scope and Applications
|
GLP 2 11 & 58 - Part 11
& 58
|
PDMA 11,
203 & 205 - Prescription
Drug Marketing
|
|
|
11
& 820 Electronic Record
and Quality Systems
|
|
|
|
The e-Newsletter of
What's New with CDER, CDRH & CBER
Distributed by the worlds
leader in Federal Regulations,
GMP Publications, Inc. & FDA.COM
Tel: 866-GXPNews (or 856-810-7331) Fax: 856-810-7339
http://www.gmppublications.com /
http://www.fda.com
John Cuspilich, Sr. Editor, GXPNews
If you would
like to advertise in this eNewsletter, call
856-810-1825
|